ANDA 70947, held by Rising Pharmaceuticals. Hydrochlorothiazide; Propranolol Hydrochloride.
As of Nov 22, 2026, ANDA 70947 (Propranolol Hydrochloride and Hydrochlorothiazide), held by Rising Pharmaceuticals, was first approved by FDA on Apr 1, 1987, with 16 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 1, 1987 | Original application | Approved | None posted |
| Propranolol Hydrochloride and Hydrochlorothiazide25MG;80MG · tablet;oral | Hydrochlorothiazide; Propranolol Hydrochloride | Discontinued |
| Propranolol Hydrochloride and Hydrochlorothiazide25MG;40MG · tablet;oral | Hydrochlorothiazide; Propranolol Hydrochloride | Discontinued |
| Aug 20, 2020 | Supplement 35Labeling · Standard review | Approved | None posted |
| Jun 1, 2015 | Supplement 29Labeling · Standard review | Approved | None posted |
| Aug 31, 2010 | Supplement 28Labeling | Approved | None posted |
| Oct 7, 2004 | Supplement 17Labeling | Approved | None posted |
| Aug 20, 2002 | Supplement 13Labeling | Approved | None posted |
| Oct 15, 2001 | Supplement 12Labeling | Approved | None posted |
| Sep 5, 2001 | Supplement 11Manufacturing | Approved | None posted |
| May 2, 2000 | Supplement 10Manufacturing | Approved | None posted |
| Sep 9, 1998 | Supplement 9Labeling | Approved | None posted |
| Feb 25, 1998 | Supplement 7Manufacturing | Approved | None posted |
| Feb 5, 1998 | Supplement 8Manufacturing | Approved | None posted |
| Mar 1, 1995 | Supplement 6Manufacturing | Approved | None posted |
| Oct 6, 1993 | Supplement 5Manufacturing | Approved | None posted |
| Feb 5, 1992 | Supplement 3Manufacturing | Approved | None posted |
| Apr 4, 1991 | Supplement 2Labeling | Approved | None posted |
| Jan 31, 1990 | Supplement 1Manufacturing | Approved | None posted |
| Apr 1, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters